Consensus 3SBio Inc.

Equities

1530

KYG8875G1029

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-04-26 am EDT			5-day change	1st Jan Change
6.08 ^HKD	+0.50%		+9.35%	-19.15%

Apr. 22	3Sbio Inc. Announces Management Changes	CI
Apr. 15	3SBIO Gets China Nod for Use of Cancer Injection in Children with Thrombocytopenia	MT

Evolution of the average Target Price on 3SBio Inc.

Price target over the last 5 years

History of analyst recommendation changes

373c91d452a17fe01.cNWXvbea0bcYG-Zq-VKlZSOWOttpMEtEOIbqHjXRVII.ArPi6sTLvN1vctMSm2TNF0nTUoRZWzEeWu6obG2bebYvtt33xdHn-FZhow~5da6e06aaebe48d0ab72529f4f84e9e3

Analyst Recommendations on 3SBio Inc.

3SBio : MSCI ESG Rating Upgraded to A, Ranking at the Forefront of the Global Biotechnology Industry

20-09-01

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

5.628 CNY

Average target price

6.887 CNY

Spread / Average Target

+22.36%

High Price Target

8.837 CNY

Spread / Highest target

+57.02%

Low Price Target

5.707 CNY

Spread / Lowest Target

+1.40%

Consensus detail

Consensus revision (last 18 months)

Ratings for 3SBio Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar